Embolization for the Treatment of Heel Pain Secondary to Plantar Fasciitis

Part of paid clinical trials in Falls Church, Virginia.

Sponsor
IR Centers
Study ID
NCT06805942
Status
Recruiting
Apply to this trial

Conditions

  • Plantar Fasciitis of Both Feet

Eligibility Criteria

Sex
ALL
Age
22 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • Lipiodol (ethiodized oil) injection — DEVICE
    Lipiodol will be used as an embolic agent for arterial embolization targeting neovascularity in the plantar fascia to reduce inflammation and pain.

Study Details

This study evaluates the feasibility and safety of using Lipiodol (ethiodized oil) as an investigational embolic agent for treating pain caused by plantar fasciitis. Participants will undergo a minimally invasive procedure called plantar fascia embolization (PFE) to reduce inflammation and pain in the affected area. The study aims to assess changes in pain levels, foot function, and any potential side effects over a six-month follow-up period.

Key Dates

Start date
Feb 15, 2025
Status verified
Jan 2025
Primary completion
Sep 30, 2025
Completion
Sep 30, 2025

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Single Intervention Group
    Participants in this arm will receive plantar fascia embolization (PFE) using Lipiodol (ethiodized oil) to treat pain caused by plantar fasciitis.

Primary Outcome Measure

Reduction in Pain (VAS Score) [ Time Frame: Baseline to 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
IR CentersFalls ChurchVirginia22043
Sindhuja Kommidi Clinical Research Coordinator, MS
[email protected]
732-783-1259
Sandeep Bagla, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Falls Church, VA

By research site
IR Centers· Falls Church, VA

Related Studies